Prenetics Global Limited

$15.47+5.85%(+$0.85)
TickerSpark Score
72/100
Solid
75
Valuation
40
Profitability
100
Growth
84
Health
60
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRE research report →

52-Week Range55% of range
Low $5.58
Current $15.47
High $23.63

Companywww.prenetics.com

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem.

CEO
Sheng Wu Yeung
IPO
2021
Employees
285
HQ
Quarry Bay, HK

Price Chart

+111.78% · this period
$22.15$14.58$7.01May 20Nov 18May 20

Valuation

Market Cap
$261.04M
P/E
-4.25
P/S
2.74
P/B
1.42
EV/EBITDA
-5.64
Div Yield
0.00%

Profitability

Gross Margin
52.99%
Op Margin
-41.27%
Net Margin
-61.32%
ROE
-36.02%
ROIC
-22.14%

Growth & Income

Revenue
$92.39M · 201.72%
Net Income
$-37,709,000 · 18.56%
EPS
$-2.68 · 26.37%
Op Income
$-38,129,000
FCF YoY
26.45%

Performance & Tape

52W High
$23.63
52W Low
$5.58
50D MA
$18.61
200D MA
$15.21
Beta
0.15
Avg Volume
213.41K

Get TickerSpark's AI analysis on PRE

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
May 19, 26Lo Hoi Chunother91,629
Mar 26, 26Shah Darshan Ravindraother0
Mar 26, 26Shah Darshan Ravindraother5,599
Mar 26, 26Yeung Danny Sheng Wuother0
Mar 26, 26Yeung Danny Sheng Wuother0
Mar 26, 26Yeung Danny Sheng Wuother0
Mar 26, 26Yeung Danny Sheng Wuother53,953
Mar 24, 26Cheng Yin Panother0
Mar 24, 26Cheng Yin Panother15,873
Mar 18, 26Lo Hoi Chunother0

Our PRE Coverage

We haven't published any research on PRE yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate PRE Report →

Similar Companies